NASDAQ · STOCK
GE HealthCare
$68.03
52W $58.75 – $89.77
55/100
$30.72B
19.5
0.84
Is GEHC Bullish or Bearish?
Mixed.
Innellis AI committee rates GE HealthCare (GEHC) Watch with a composite score of 55/100
, based on 7 analysts with 43% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +4.53 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -15.47 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — market regime is bullish (bull market -- normal position sizing). Risk Analyst remains cautious — bollinger bandwidth of 18.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 18.8% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.33 across 53 articles, 14d) — News
Bear Case
- EPS declining -12.3% YoY despite any revenue growth — Growth
- Bollinger bandwidth of 18.2% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
55/100
Agreement
43%
Analysts
7
Conviction
Contested
Sector Rank
Top 63%
of 93 Healthcare peers
Value Analyst
bullish
63
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 18.8% shows genuine earnings power backing the valuation
Growth Analyst
neutral
48
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -12.3% YoY despite any revenue growth
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 18.2% signals elevated volatility
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
68
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 53 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 53.4 to 55.5.
- Committee agreement fell notably from 57% to 43%.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
60.1
Neutral
MACD Histogram
0.764
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$63.81
Resistance
$75.92
Bollinger %B
0.81
Inside Bands
Price vs Moving Averages
EMA 9
$66.02
Above
EMA 21
$64.80
Above
EMA 50
$64.86
Above
EMA 200
$70.44
Below
Fundamental Analysis
Valuation
87
Growth
63
Profitability
0
Financial Health
49
Cash Flow
37
Valuation
P/E Ratio
19.5×
P/B Ratio
2.81×
PEG Ratio
-0.67
Dividend Yield
0.00%
52W High
$89.77
52W Low
$58.75
Quality & Growth
ROE
20.1%
ROA
5.7%
Gross Margin
42.9%
Operating Margin
12.7%
Revenue Growth YoY
—
Debt / Equity
0.92
AI Fundamental Assessment
P/E ratio of 19.5 (inexpensive relative to a 15-40x range); Price-to-book of 2.8x; PEG ratio of -0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.4%; Current ratio of 1.02 (tight short-term liquidity); Debt-to-equity of 0.92; Free cash flow margin of 0.6% (thin cash generation); Free cash flow per share is positive (1.98); Most recent quarter beat estimates by 7.0%; EPS growth accelerating (-31.2% -> +14.1% QoQ); Average YoY EPS growth of 6.6%; Analyst estimates falling over recent quarters
Get the Full GEHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →